Subtext

Charles River Laboratories International, Inc. CRL

SectorHealth Care
Transcripts21
Date range2020-05-10 – 2025-05-07
Calls charted21

Sentiment timeline

Net Loughran-McDonald sentiment per call (×1000), earliest → latest.

-17-9+0+9+172020 Q12020 Q42021 Q32022 Q22023 Q12023 Q42024 Q32020 Q1 · Overall: -0.22020 Q2 · Overall: +6.72020 Q3 · Overall: +15.22020 Q4 · Overall: +7.82021 Q1 · Overall: +6.72021 Q2 · Overall: +13.42021 Q3 · Overall: +8.92021 Q4 · Overall: +13.42022 Q1 · Overall: +12.92022 Q2 · Overall: +6.72022 Q3 · Overall: +7.92022 Q4 · Overall: +4.02023 Q1 · Overall: +7.62023 Q2 · Overall: +4.92023 Q3 · Overall: +0.92023 Q4 · Overall: +6.72024 Q1 · Overall: +4.02024 Q2 · Overall: +0.32024 Q3 · Overall: +8.42024 Q4 · Overall: +3.02025 Q1 · Overall: +4.0
Overall

CEO vs CFO

Average sentiment of each executive's remarks per call. Divergence is a signal.

-28-14+0+14+282020 Q12020 Q42021 Q32022 Q22023 Q12023 Q42024 Q32020 Q1 · CEO: +1.22020 Q2 · CEO: +8.52020 Q3 · CEO: +17.72020 Q4 · CEO: +8.02021 Q1 · CEO: +7.72021 Q2 · CEO: +18.02021 Q3 · CEO: +17.42021 Q4 · CEO: +17.82022 Q1 · CEO: +16.32022 Q2 · CEO: +13.32022 Q3 · CEO: +14.62022 Q4 · CEO: +5.72023 Q1 · CEO: +13.12023 Q2 · CEO: +10.72023 Q3 · CEO: +5.62023 Q4 · CEO: +10.22024 Q1 · CEO: +8.82024 Q2 · CEO: +4.42024 Q3 · CEO: +11.92024 Q4 · CEO: +9.12025 Q1 · CEO: +6.92020 Q1 · CFO: +11.02020 Q2 · CFO: +12.72020 Q3 · CFO: +18.42020 Q4 · CFO: +15.52021 Q1 · CFO: +21.42021 Q2 · CFO: +11.72021 Q3 · CFO: +4.62021 Q4 · CFO: +20.42022 Q1 · CFO: +24.42022 Q2 · CFO: +9.02022 Q3 · CFO: +5.52022 Q4 · CFO: +9.52023 Q1 · CFO: +3.92023 Q2 · CFO: +8.92023 Q3 · CFO: +0.32023 Q4 · CFO: +7.32024 Q1 · CFO: +6.82024 Q2 · CFO: -4.92024 Q3 · CFO: +10.22024 Q4 · CFO: +0.02025 Q1 · CFO: +12.6
CEOCFO

Prepared remarks vs Q&A

Scripted tone vs unscripted answers. The gap is information.

-34-17+0+17+342020 Q12020 Q42021 Q32022 Q22023 Q12023 Q42024 Q32020 Q1 · Prepared remarks: +9.32020 Q2 · Prepared remarks: +8.12020 Q3 · Prepared remarks: +26.32020 Q4 · Prepared remarks: +23.62021 Q1 · Prepared remarks: +29.22021 Q2 · Prepared remarks: +26.22021 Q3 · Prepared remarks: +16.82021 Q4 · Prepared remarks: +26.62022 Q1 · Prepared remarks: +20.82022 Q2 · Prepared remarks: +14.92022 Q3 · Prepared remarks: +13.92022 Q4 · Prepared remarks: +12.82023 Q1 · Prepared remarks: +16.12023 Q2 · Prepared remarks: +15.92023 Q3 · Prepared remarks: +7.82023 Q4 · Prepared remarks: +11.92024 Q1 · Prepared remarks: +13.72024 Q2 · Prepared remarks: +0.42024 Q3 · Prepared remarks: +9.82024 Q4 · Prepared remarks: +9.52025 Q1 · Prepared remarks: +13.52020 Q1 · Q&A responses: -5.02020 Q2 · Q&A responses: +5.12020 Q3 · Q&A responses: +8.72020 Q4 · Q&A responses: +5.72021 Q1 · Q&A responses: +5.52021 Q2 · Q&A responses: +2.32021 Q3 · Q&A responses: +7.52021 Q4 · Q&A responses: +9.52022 Q1 · Q&A responses: +11.92022 Q2 · Q&A responses: +8.32022 Q3 · Q&A responses: +8.22022 Q4 · Q&A responses: +1.62023 Q1 · Q&A responses: +6.02023 Q2 · Q&A responses: +4.92023 Q3 · Q&A responses: +1.42023 Q4 · Q&A responses: +6.92024 Q1 · Q&A responses: +7.42024 Q3 · Q&A responses: +8.82024 Q4 · Q&A responses: +3.02025 Q1 · Q&A responses: +3.0
Prepared remarksQ&A responses

Tone vs forward expectations

Management tone next to Wall Street's forward-looking numbers (glopardo): the 12-month forward EPS estimate and the forward P/E per call.

Forward EPS estimate

$7.01$9.94$12.872020 Q12020 Q42021 Q32022 Q22023 Q12023 Q42024 Q32020 Q1: $7.732020 Q2: $7.412020 Q3: $8.142020 Q4: $8.812021 Q1: $9.482021 Q2: $10.752021 Q3: $11.292021 Q4: $11.502022 Q1: $12.082022 Q2: $12.472022 Q3: $11.802022 Q4: $11.442023 Q1: $10.762023 Q2: $11.222023 Q3: $11.492023 Q4: $10.922024 Q1: $11.372024 Q2: $11.702024 Q3: $10.42

Forward P/E

10.7025.8841.062020 Q12020 Q42021 Q32022 Q22023 Q12023 Q42024 Q32020 Q1: 12.792020 Q2: 24.042020 Q3: 27.282020 Q4: 27.262021 Q1: 30.862021 Q2: 32.832021 Q3: 38.972021 Q4: 31.562022 Q1: 22.412022 Q2: 17.072022 Q3: 17.142022 Q4: 18.742023 Q1: 18.122023 Q2: 18.482023 Q3: 17.712023 Q4: 19.962024 Q1: 22.982024 Q2: 17.932024 Q3: 19.77

Divergence watch ⚑

Quarters where tone and the forward EPS estimate moved opposite ways.

  • 2020 Q2 tone ↑ +6.8 fwd EPS ↓ -0.32 Tone rose while the forward EPS estimate was cut.
  • 2020 Q4 tone ↓ -7.4 fwd EPS ↑ +0.67 Tone cooled even as the forward EPS estimate rose.
  • 2021 Q3 tone ↓ -4.5 fwd EPS ↑ +0.54 Tone cooled even as the forward EPS estimate rose.
  • 2022 Q2 tone ↓ -6.2 fwd EPS ↑ +0.39 Tone cooled even as the forward EPS estimate rose.
  • 2023 Q1 tone ↑ +3.6 fwd EPS ↓ -0.68 Tone rose while the forward EPS estimate was cut.
  • 2023 Q2 tone ↓ -2.6 fwd EPS ↑ +0.47 Tone cooled even as the forward EPS estimate rose.
  • 2023 Q3 tone ↓ -4.0 fwd EPS ↑ +0.27 Tone cooled even as the forward EPS estimate rose.
  • 2023 Q4 tone ↑ +5.8 fwd EPS ↓ -0.57 Tone rose while the forward EPS estimate was cut.
  • 2024 Q1 tone ↓ -2.7 fwd EPS ↑ +0.45 Tone cooled even as the forward EPS estimate rose.
  • 2024 Q2 tone ↓ -3.7 fwd EPS ↑ +0.33 Tone cooled even as the forward EPS estimate rose.
  • 2024 Q3 tone ↑ +8.1 fwd EPS ↓ -1.28 Tone rose while the forward EPS estimate was cut.

Recent transcripts

CallDateSentiment ×1000Fwd EPSFwd P/E
2025 Q12025-05-07+4.0——View →
2024 Q42025-02-19+3.0——View →
2024 Q32024-11-06+8.4$10.4219.8View →
2024 Q22024-08-07+0.3$11.7017.9View →
2024 Q12024-05-09+4.0$11.3723.0View →
2023 Q42024-02-14+6.7$10.9220.0View →
2023 Q32023-11-08+0.9$11.4917.7View →
2023 Q22023-08-09+4.9$11.2218.5View →